Active — Not RecruitingNot Applicable

Horizons Chronic Graft-Versus-Host-Disease Study

United States20 participantsStarted 2023-12-27

Plain-language summary

This research is being done to evaluate the feasibility of the Horizons Program, a group-based behavioral intervention, to enhance quality of life in patients with chronic graft-versus-host disease.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * underwent allogeneic hematopoietic stem cell transplant * have moderate to severe chronic graft versus host disease * currently receiving care at the Sylvester Comprehensive Cancer Center Bone Marrow Transplant Program * able to participate in a group intervention in English or Spanish language Exclusion Criteria: * comorbid conditions or cognitive impairment that the treating clinician believes prohibits informed consent or participation in the intervention * vulnerable patients, defined here as prisoners and pregnant women

What they're measuring

Percentage of participant enrollment

Timeframe: Baseline (pre-intervention) to 10-week follow-up

Percentage of participant attendance

Timeframe: Baseline (pre-intervention) to 10-week follow-up

Percentage of participant retention

Timeframe: Baseline (pre-intervention) to 10-week follow-up

Trial details

NCT IDNCT06160986

SponsorUniversity of Miami

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-12

View on ClinicalTrials.gov More Graft Vs Host Disease trials